Pharma-Bio Serv, Inc. Quarterly Liabilities, Current in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Pharma-Bio Serv, Inc. quarterly Liabilities, Current history and growth rate from Q3 2010 to Q2 2024.
  • Pharma-Bio Serv, Inc. Liabilities, Current for the quarter ending July 31, 2024 was $1.9M, a 22.5% decline year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.9M -$551K -22.5% Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $2.2M -$47.5K -2.12% Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $3.68M +$1.72M +87.5% Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $2.15M +$46K +2.18% Oct 31, 2023 10-Q 2024-09-16
Q2 2023 $2.45M +$292K +13.5% Jul 31, 2023 10-Q 2023-09-14
Q1 2023 $2.24M +$53.6K +2.44% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 $1.96M -$360K -15.5% Jan 31, 2023 10-Q 2023-03-17
Q3 2022 $2.11M -$561K -21% Oct 31, 2022 10-K 2024-01-29
Q2 2022 $2.16M -$203K -8.6% Jul 31, 2022 10-Q 2022-09-14
Q1 2022 $2.19M -$1.09M -33.1% Apr 30, 2022 10-Q 2022-06-14
Q4 2021 $2.32M -$3.21M -58.1% Jan 31, 2022 10-Q 2022-03-17
Q3 2021 $2.67M -$1.12M -29.6% Oct 31, 2021 10-K 2023-01-30
Q2 2021 $2.36M -$1.39M -37.1% Jul 31, 2021 10-Q 2021-09-14
Q1 2021 $3.28M +$566K +20.9% Apr 30, 2021 10-Q 2021-06-14
Q4 2020 $5.54M +$3.59M +184% Jan 31, 2021 10-Q 2021-03-17
Q3 2020 $3.79M +$122K +3.33% Oct 31, 2020 10-K 2022-02-11
Q2 2020 $3.75M +$1.65M +78.5% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 $2.71M +$775K +40% Apr 30, 2020 10-Q 2020-06-15
Q4 2019 $1.95M -$105K -5.13% Jan 31, 2020 10-Q 2020-03-16
Q3 2019 $3.67M +$1.1M +43.1% Oct 31, 2019 10-K 2021-02-01
Q2 2019 $2.1M +$48.2K +2.35% Jul 31, 2019 10-Q 2019-09-16
Q1 2019 $1.94M -$15K -0.77% Apr 30, 2019 10-Q 2019-06-14
Q4 2018 $2.05M +$567K +38.2% Jan 31, 2019 10-Q 2019-03-18
Q3 2018 $2.57M +$1.02M +66.3% Oct 31, 2018 10-K 2020-01-29
Q2 2018 $2.05M +$648K +46.1% Jul 31, 2018 10-Q 2018-09-14
Q1 2018 $1.95M +$552K +39.5% Apr 30, 2018 10-Q 2018-06-14
Q4 2017 $1.48M -$93.4K -5.92% Jan 31, 2018 10-Q 2018-03-19
Q3 2017 $1.54M -$616K -28.5% Oct 31, 2017 10-K 2019-01-29
Q2 2017 $1.41M -$265K -15.9% Jul 31, 2017 10-Q 2017-09-14
Q1 2017 $1.4M -$353K -20.2% Apr 30, 2017 10-Q 2017-06-14
Q4 2016 $1.58M +$82.9K +5.55% Jan 31, 2017 10-Q 2017-03-17
Q3 2016 $2.16M +$34.7K +1.63% Oct 31, 2016 10-K 2018-01-29
Q2 2016 $1.67M -$80.9K -4.62% Jul 31, 2016 10-Q 2016-09-14
Q1 2016 $1.75M -$222K -11.3% Apr 30, 2016 10-Q 2016-06-14
Q4 2015 $1.5M -$698K -31.8% Jan 31, 2016 10-Q 2016-03-16
Q3 2015 $2.12M -$502K -19.1% Oct 31, 2015 10-K 2017-01-31
Q2 2015 $1.75M -$511K -22.6% Jul 31, 2015 10-Q 2015-09-14
Q1 2015 $1.97M -$445K -18.4% Apr 30, 2015 10-Q 2015-06-15
Q4 2014 $2.19M -$97.7K -4.27% Jan 31, 2015 10-Q 2015-03-17
Q3 2014 $2.63M -$555K -17.4% Oct 31, 2014 10-K 2016-01-29
Q2 2014 $2.26M -$7.89K -0.35% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 $2.42M -$60K -2.42% Apr 30, 2014 10-Q 2014-06-16
Q4 2013 $2.29M +$91.8K +4.17% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 $3.18M +$405K +14.6% Oct 31, 2013 10-K 2015-01-29
Q2 2013 $2.27M +$174K +8.3% Jul 31, 2013 10-Q 2013-09-16
Q1 2013 $2.48M +$577K +30.3% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 $2.2M +$136K +6.61% Jan 31, 2013 10-Q 2013-03-18
Q3 2012 $2.78M +$252K +9.98% Oct 31, 2012 10-K 2014-01-29
Q2 2012 $2.1M +$144K +7.35% Jul 31, 2012 10-Q 2012-09-14
Q1 2012 $1.9M Apr 30, 2012 10-Q 2012-06-14
Q4 2011 $2.06M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 $2.52M +$1.09M +75.9% Oct 31, 2011 10-K 2013-01-29
Q2 2011 $1.95M Jul 31, 2011 10-Q 2011-09-14
Q3 2010 $1.43M Oct 31, 2010 10-K/A 2012-01-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.